Difficulty: Medium
Average Score: 67%
Practice
Indicate the nondepolarizing agent, which has the fastest onset of effect:
Correct answer
B
Rationale
In this scenario, the correct answer is B) Rapacuronium. The rationale behind this choice lies in understanding the pharmacological properties of nondepolarizing neuromuscular blocking agents. Rapacuronium is known for its rapid onset of action, making it the nondepolarizing agent with the fastest onset among the options provided.
Succinylcholine (A) is actually a depolarizing neuromuscular blocking agent, not a nondepolarizing one. Its mechanism of action differs from nondepolarizing agents, leading to a different onset time.
Pancuronium (C) is a nondepolarizing agent, but it is not known for its rapid onset of action compared to Rapacuronium. Tubocurarine (D) is also a nondepolarizing agent, but it is one of the slowest in terms of onset among this class of drugs.
Educationally, understanding the onset of action of different pharmacological agents is crucial for healthcare professionals, especially in scenarios where quick neuromuscular blockade is required, such as during surgeries. Knowing the specific properties of each drug helps in making informed decisions regarding drug selection based on the clinical situation at hand.
Succinylcholine (A) is actually a depolarizing neuromuscular blocking agent, not a nondepolarizing one. Its mechanism of action differs from nondepolarizing agents, leading to a different onset time.
Pancuronium (C) is a nondepolarizing agent, but it is not known for its rapid onset of action compared to Rapacuronium. Tubocurarine (D) is also a nondepolarizing agent, but it is one of the slowest in terms of onset among this class of drugs.
Educationally, understanding the onset of action of different pharmacological agents is crucial for healthcare professionals, especially in scenarios where quick neuromuscular blockade is required, such as during surgeries. Knowing the specific properties of each drug helps in making informed decisions regarding drug selection based on the clinical situation at hand.